The Ethics of Elective Growth Hormone Therapy in Children

with Idiopathic Short Stature

 

Kevin Leslie Kecskemeti and Samuel Reis-Dennis

 

In this article, we analyze the ethics of elective growth hormone (GH) therapy in children with idiopathic short stature (ISS). We discuss recent clinical research regarding the efficacy, side-effects, and risks of GH therapy, and argue that GH therapy is ethically unjustifiable for most children with ISS.

 

 

Read the full text

 

Institutional Subscribers

 

Individual Subscribers

 

Nonsubscriberspurchase a .pdf of the article